Daniel Spilman, MD
Pediatric Otolaryngology · Santa Cruz, CANPI 1619923711
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by GSK at 46.9% of the total. That places this record below the midpoint for pediatric otolaryngology clinicians in CA, where the typical reported total is $583.
Across 5 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$49
- Sanofi$25
- Intersect ENT, Inc.$19
- Stryker$12
What the payments were for
- Food & beverage$104100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 2 | $49 |
| Sanofi | 1 | $25 |
| Intersect ENT, Inc. | 1 | $19 |
| Stryker | 1 | $12 |
How this compares
$104 in reported general payments places this provider in the 10th percentile of 66 pediatric otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 24 | $5,189 |
| Azelastine Hcl | 120 | $5,124 |
| Fluticasone Propionate | 108 | $2,269 |
| Ipratropium Bromide | 22 | $1,602 |
| Ofloxacin | 18 | $1,299 |
| Omeprazole | 39 | $370 |
| Montelukast Sodium | 30 | $346 |
| Doxycycline Hyclate | 14 | $245 |
| Betamethasone Dipropionate | 12 | $239 |
| Prednisone | 32 | $226 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 16 | $189 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $107 |
| Hydroxyzine Hcl | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Other pediatric otolaryngology in Santa Cruz
- Seth PranskySan Diego$76K
- Vijay PatelSan Diego$28K
- Kevin HuohOrange$26K
- Rose EapenManhattan Beach$12K
- Andrew BirkelandPalo Alto$8K
- Kathy YuHuntington Beach$8K
- Namrata VarmaLong Beach$7K
- Alan ChengPalo Alto$4K
- Mai Thy TruongPalo Alto$4K
- Qiu ZhongMadera$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.